FAK and paxillin. VEGF binding to KDR(Y951F) and KDR(Y996F) expressing cells resulted in phosphorylation of all cellular substrates tested, although the level of PLCg phosphorylation was decreased for KDR(Y996F). The decreased level of PLCg phosphorylation was not because PLCgcontaining SH2 domains bind to the Y996 autophosphorylation site. We conclude that there exists receptor autophosphorylation sites not previously identi®ed which allow for signaling via PLCg, as well as p 125 FAK and paxillin. VEGF binding to cells expressing KDR mutated at both tyrosine's 1054 and 1059 activated receptor autophosphorylation but at a level which was only 10% of that seen for cells expressing native receptor. Tyrosine phosphorylation of cell signaling proteins was not observed in KDR(Y1054,1059) expressing cells. Utilizing an in vitro assay which directly measures receptor catalytic activity allowed us to determine that the tyrosine kinase activity of the native receptor was signi®cantly greater than that for the double mutant. We conclude from this result that VEGF-induced autophosphorylation at tyrosines 1054 and 1059 is a required step for allowing maximal KDR kinase activity. Maximal rates of receptor kinase activity is required for VEGF-induced receptor internalization, as internalization was delayed in the KDR(Y1054,1059F) expressing cells when compared to cells expressing native receptor.
Keywords: VEGF; KDR receptor; autophosphorylation; angiogenesis Introduction Angiogenesis, the formation of new blood capillaries, is an important component of normal physiological processes such as wound healing and development (Folkman and Shing, 1992) . Angiogenesis also contributes to several pathological situations including tumor growth (Folkman, 1991) , rheumatoid arthritis (Fava et al., 1994) and degenerative eye disorders (Garner, 1994) . Vascular endothelial cells are critical to this process, since angiogenesis occurs via migration of sprouts of endothelial cells from pre-existing vessels (Folkman and Shing, 1992) . Angiogenesis is a complex process involving endothelial cell movement and proliferation, and endothelial cell mediated degradation of extracellular matrix. These events are activated by growth factors binding to endothelial cell surface receptors.
For several reasons it is thought that vascular endothelial growth factor (VEGF) (Dvorak et al., 1995; Ferrara and Davis-Smith, 1997 ) is a key angiogenic growth factor. VEGF elicits a strong angiogenic response in a variety of in vivo models (Leung et al., 1989; Tolentino et al., 1996) , and induces con¯uent microvascular endothelial cells to invade collagen gels to form capillary-like structures (Pepper et al., 1991) . VEGF is also known as vascular permeability factor and an increase in microvascular permeability may be a crucial step in angiogenesis associated with tumors and wounds (Senger et al., 1983) . VEGF stimulates several endothelial cell responses, including proliferation (Leung et al., 1989; Gospodarowicz et al., 1989) and the secretion of matrix degrading enzymes (Pepper et al., 1991) . VEGF's actions are by and large speci®c to endothelial cells, and cell surface receptors are predominantly expressed on endothelial cells (Vaisman et al., 1990; Broxmeyer et al., 1995) . The expression of VEGF has been correlated both temporally and spatially with the onset of several physiological situations involving neovascularization (Cullinan-Bove and Koos, 1993; Brown et al., 1993; Aiello et al., 1994) . A necessary role of VEGF in tumor angiogenesis has been demonstrated by the ®nding that its inhibition with neutralizing antibodies (Kim et al., 1993) or a dominant-negative fetal liver kinase-1 (FLK1) receptor (Millauer et al., 1994) inhibits tumor angiogenesis and the growth of solid tumors.
VEGF exhibits high anity binding to two distinct receptor tyrosine kinases, the fms-like tyrosine kinase Flt1 (Shibuya et al., 1990; De Vries et al., 1992) , and the kinase insert domain containing receptor KDR (Terman et al., 1992) , the human homologue of FLK1 (Matthews et al., 1991) . Both receptors contain an insert sequence within their catalytic domains and seven extracellular immunoglobulin-like domains. While the functional dierences of VEGF signaling through KDR/FLK1 versus Flt1 in adults is not known, targeting studies suggest that during the early stages of embryogenesis, FLK1 functions in the proliferation of endothelial cells (Shalaby et al., 1995) and Flt1 seems to be required more for dierentiation and vascular organization (Fong et al., 1995) .
It is not clear whether the Flt1 or KDR tyrosine kinases phosphorylate and activate similar or very dierent endothelial cell substrates. Phospholipase C-g (PLCg), Nck, phosphatidylinositol 3'-kinase and GTPase activating protein (GAP) are tyrosine phosphorylated in endothelial cells in the presence of VEGF (Guo et al., 1995) . Another recent study showed that VEGF stimulates tyrosine phosphorylation and recruitment of new focal adhesions of focal adhesion kinase (p 125 FAK) and paxillin (Abedi and Zachary, 1997) . It is not known from these results which VEGF receptor (Flt1 or KDR/FLK1) is involved in the phosphorylation and activation of each substrate. PLCg and GAP are tyrosine phosphorylated in NIH3T3 cells expressing Flt1, and MAP kinase and PLCg are phosphorylated in NIH3T3 cells expressing KDR (Seetharam et al., 1995 , Takahashi and Shibuya, 1997 and Waltenberger et al., 1994 .
While the speci®c signaling pathways mediated by the VEGF receptors are just starting to be clari®ed, there is considerable information from studies using other receptor tyrosine kinases on general signal transduction mechanisms. Growth factor binding to cells leads to receptor dimerization and then receptor autophosphorylation (Ullrich and Schlessinger, 1990) which allows for the recruitment of src-homology-2 (SH2) domain-containing signaling proteins to speci®c phosphorylated tyrosines. Growth factor induced receptor kinase activity is also required for functions other than the recruitment of cell signaling proteins. For example, autophosphorylation of tyrosines contained in the insulin receptor (IR) (Wilden et al., 1992; Ellis et al., 1986) , ®broblast growth factor receptor-1 (Mohammadi et al., 1996) and c-Met receptor (Longati et al., 1994) catalytic domains is required for maximal kinase activity. In addition, epidermal growth factor receptor (EGFR) kinase activity is required for maximal rates of receptor internalization, although it is not clear whether autophosphorylation is required (Wiley et al., 1991) .
We have previously reported the identi®cation of four autophosphorylation sites on the KDR receptor (Dougher-Vermazen et al., 1994) . Two of the sites (tyrosines 951 and 996) are contained within the kinase insert domain and the other two (tyrosines 1054 and 1059) are contained within the receptor catalytic domain. The autophosphorylation sites were identi®ed after expression of a catalytically active receptor cytosolic domain in bacteria. It remains to be con®rmed whether these four tyrosines are autophosphorylated in the intact receptor after incubation with growth factor. In addition, the cellular consequences of autophosphorylation of the receptor at each tyrosine remains to be determined. In this manuscript, we have taken a mutagenesis approach to address these issues.
Results
Experiments were ®rst done to determine whether KDR expression in human embryonic kidney epithelial (293) cells allows for signaling events that have previously been reported in studies using endothelial cells. Figure 1 shows (Abedi and Zachary, 1997; Takahashi and Shibuya, 1997) .
In order to determine the functional consequence of receptor autophosphorylation at tyrosines 951, 996, 1054 and 1059, we took a mutagenesis approach by replacing appropriate nucleotides with those that encode phenylalanine. Three receptor constructs were made. In construct one, tyrosine 951 was replaced by phenylalanine (the protein expressed from this construct will be identi®ed as KDR(Y951F). In construct two, tyrosine 996 was replaced (KDR(Y996F)), and in construct three, both tyrosines 1054 and 1059 were replaced (KDR (Y1054,1059) ). The native and mutant receptors were then expressed in 293 cells. were treated with VEGF for 1 h at 48C, a protocol which prevents receptor internalization. Tyrosine phosphorylated proteins were immunoprecipitated using an agarose conjugated anti-phosphotyrosine antibody and Western blot analysis was done using an anti-KDR antibody Figure 4 Comparison of VEGF-induced receptor autophosphorylation in KDR versus KDR(Y1054,1059F) expressing 293 cells. Incubation of cells with VEGF was done at 378C for the times indicated. Tyrosine phosphorylated proteins were immunoprecipitated using an agarose conjugated anti-phosphotyrosine antibody and Western blot analysis was done using an anti-KDR antibody Experiments were then done to clarify why the phosphorylation of PLCg is reduced for KDR(Y996F). PLCg contains two SH2 domains, each of which could potentially interact with a receptor autophosphorylation site. Our working hypothesis for these experiments was that one of these SH2 domains interacts with Y996, and so PLCg binds to the receptor (via its other SH2 domain) but with a reduced anity. In order to test this hypothesis, we made cDNA constructs encoding both SH2 domains. The construct was expressed in bacteria as a GST-fusion protein and puri®ed on a glutathione anity column. Biotinylated peptides containing Y996 (EDLYKDFLATL) and Y951 (GKDYVAGAIPV) were synthesized using tyrosine phosphate. In addition, a phosphorylated peptide (DNDYIIPLP) corresponding to a known PLCg binding site on the platelet derived growth factor receptor (PDGFR) was also made. In order to test whether the PLCg-derived SH2 domains can interact with the KDR-derived phosphorylated peptides, we coupled 5 mg peptide with streptavidincoupled agarose, washed the beads, and then incubated with 10 mg of SH2 domain containing recombinant protein. The beads were washed, and Western analysis was done using an anti-GST antibody to determine whether the recombinant PLCg-derived protein interacted with the phosphorylated peptides. Figure 6 shows that the PLCg-derived protein containing both SH2 domains did not interact with either the Y951 or Y996 containing peptides, but did bind to the PDGFR-derived peptide, and we conclude that neither KDR tyrosines 951 or 996 allow for signal transduction via PLCg. A series of experiments were then done to clarify why receptor autophosphorylation in KDR (Y1054,1059F) and KDR(Y996F) expressing cells is reduced. We reasoned that there could be two explanations for these observations. First, the mutant receptors, while having the same intrinsic kinase activity as the native receptor, contain less autophosphorylation sites and so would not be expected to label as intensely. Second, it is possible that replacement of these tyrosines inhibits intrinsic kinase activity, and this contributes to the decrease in phosphorylation.
Experiments were designed to compare the intrinsic kinase activities of the native versus KDR (Y1054, 1059F) and KDR (Y996F) receptors. Kinase activity was measured in receptor samples obtained by immunoprecipitating cellular extracts with an anti-KDR antibody. More speci®cally, the protocol involved growing cells to con¯uence on 10 cm dishes, adding VEGF to activate receptor kinase activity, and then extracting the cells with detergent. The receptors were immunoprecipitated by adding an anti-KDR antibody and protein A sepharose. The resins were then washed several times to remove nonspeci®cally associated proteins, and kinase activity was measured at 48C by incubating the immunoprecipitates (including resin) with poly (Glu:Tyr 4 : 1), [ 33 P]ATP, and MnCl 2 . Incorporation of label into the peptide was quantitated using phosphocellulose ®lters. To control for the diering levels of puri®ed receptor, each preparation was calibrated for protein by doing Western blot analysis using an anti-KDR antibody (data not shown). Thus, approximately equivalent amounts of KDR protein was present in the in vitro kinase assay. As shown in Figure 7 , catalytic Interaction of PLCg-derived SH2 domains with KDR autophosphorylation site peptides. Biotinylated peptides containing KDR Y951 or Y996 and a known PLCg-interacting peptide derived from the PDGFR were synthesized using tyrosine phosphate. The peptides were bound to streptavidin-coupled agarose and then incubated with the bacterially expressed PLCgderived SH2 domains, which was expressed as a GST-fusion protein. The resins were washed with buer in order to remove unbound recombinant SH2 domain protein, and then boiled in gel sample buer. Western blot analysis was done using an anti-GST antibody. For lane 1, no peptide was bound to the streptavidin-coupled agarose. Lane 2 used the KDR Y951-containing peptide. Lane 3 used the KDR Y996-containing peptide. Lane 4 used the PDGFR-derived peptide activity of the native receptor and KDR (Y996F) are tenfold greater than that for the mutant receptor. We conclude from this experiment that the decreased autophosphorylation seen in cells expressing KDR (Y1054,1059F) versus native receptors (Figure 4) , and the decreased phosphorylation of cellular substrates seen in the KDR (Y1054,1059F) cells ( Figure 5 ) is at least partially due to a decreased intrinsic kinase activity. Figure 7 , together with the data shown in Figure 3 , indicates that Y996 is a major autophosphorylation site.
It is known that binding of growth factors, cytokines and hormones to their cell surface receptors often leads to internalization of the ligand/receptor complex and subsequent degradation of the receptor. In this manner, cells can regulate their responsiveness to growth factors by altering their levels of cell surface receptors. Tyrosine kinase activity has been shown to be required for growth factor induced receptor internalization (Wiley et al., 1991) Figure 7 Phosphorylation of a peptide substrate by anity puri®ed native, KDR(Y996F) and KDR(Y1054,1059F) receptors. Cells were treated with 50 ng/ml VEGF for 1 h at 48C, and then extracted with detergent. The receptors were then immunoprecipitated with an anti-KDR antibody as described in the Materials and methods. Receptor kinase activity was then measured in the immunoprecipitates using [ ]VEGF radioligand binding was done at each of these temperatures for the time periods indicated in the ®gure. The acid wash protocol (described in the Materials and methods) was used to determine the number of total cellular receptors (cell surface plus internalized) and the number of internalized receptors (number of cell associated receptors after acid wash). Total receptors are indicated by squares, and internal receptors by diamonds. (a) was at 378C, (b) at 238C, and (c) at 48C Figure 9 Comparison of the rate of VEGF-induced receptor internalization for BAE (diamonds), 293 cells expressing native KDR (squares) and KDR(Y1054,1059F) (circles) cells. Radioligand binding was done at 378C. The data is quantitated as the per cent of total receptors that are internalized; that is the ratio of internalized (acid wash resistant) to total receptors of the total cellular radioligand that is internalized. For cells expressing the native receptor, 25 min is required for 50% of cell associated [ 125 I]VEGF to be internalized, while for cells expressing the mutant receptor 55 min is required. We conclude from this experiment that growth factor-induced receptor internalization requires maximal kinase activity.
Discussion
Our data indicates that autophosphorylation of KDR tyrosines 951 and 996 does not mediate VEGF-induced phosphorylation of PLCg, p 125 FAK or paxillin. This implies that VEGF induces receptor autophosphorylation at other receptor tyrosines allows for signaling to the three tested cellular phosphoproteins. The reason why our previous study did not identify these sites is not clear, but may relate to the fact that the previously identi®ed autophosphorylation sites were determined using the receptor cytosolic domain after expression in bacteria. It is possible that the autophosphorylation pattern seen using the bacterial system may not fully re¯ect the pattern seen when using the intact receptor after binding VEGF. Alternatively, the protocols used to identify autophosphorylation sites using the bacterial system may not have been sensitive enough for identifying sites other than tyrosines 951, 996, 1054 or 1059. Further experimentation is required to identify the other receptor autophosphorylation sites and to determine which of them mediates VEGF signaling via PLCg, p 125 FAK and paxillin. A recent study in the literature veri®es our conclusion that PLCg does not interact at receptor tyrosines 951 or 996, but does so at tyrosines 801 and 1175 (Cunningham et al., 1998) . For this study the authors used a yeast two hybrid system.
The fact that our current studies did not clarify the signaling pathways mediated by KDR tyrosine 951 or 996 leaves some concern as to whether these tyrosines are phosphorylated in the intact receptor after binding VEGF, although this concern is diminished by several other considerations. First, the experiment shown in Figure 3 indicates that the intensity of VEGF-induced autophosphorylation is signi®cantly reduced when using receptor mutated at Y996, con®rming that this is a major site of autophosphorylation. Second, tyrosines 951 and 996 are the only two tyrosines in the receptor's kinase insert domain, and there is strong evidence from studies using the PDGFR and cFMS that autophosphorylation of tyrosines in this domain leads to important signaling events (Fantl et al., 1992) . Third, there is now strong evidence from studies using other receptor tyrosine kinases that autophosphorylation sites identi®ed using the cytosolic domains are legitimate sites in the intact receptor (Margolis et al., 1989; Mohammadi et al., 1991) . In view of these considerations, it remains an important issue as to which signaling proteins interact with KDR tyrosines 951 and 996 and what are the cellular consequences of these interactions.
Our ®nding that autophosphorylation sites within the KDR kinase domain are critical for maximal catalytic activity is similar to what had previously been reported for the insulin receptor kinase (IR) (Wilden et al., 1992) and other receptor kinases. The cellular bene®t of the activation mechanism whereby autophosphorylation in the receptor kinase domain leads to maximal catalytic activity is now starting to be understood (Hubbard et al., 1998) . It has been speculated that in the unphosphorylated IR there are structural aspects of the receptor's cytosolic domain which inhibit kinase activity, and that autophosphorylation in the kinase domain relieves that inhibition. This may be important because if the inhibition did not occur there may be receptor activation by random collisions between monomeric receptors, and these may be sucient for allowing cellular activation even in the absence of growth factor.
The crystal structure of the IR tyrosine kinase domain has been determined (Hubbard et al., 1994) and the resulting information on the molecular interactions which allow activation of the IR kinase is informative for understanding biochemical aspects of KDR catalytic activity. In the IR, the molecular nature of catalytic inhibition involves interference with MgATP coordination at conserved Asp-Phe-Gly triad at the beginning of the kinase's A-loop. Signi®cantly, the Asp-Phe-Gly sequence is found at a corresponding position in KDR suggesting that catalytic inhibition in unphosphorylated receptor also occurs KDR, and that VEGF-induced phosphorylation of tyrosines 1054 and 1059 relieves that inhibition. Both the IR and the FGFR contain a conserved proline which is also thought to participate in catalytic inhibition of the unphosphorylated receptors. KDR contains a corresponding proline further strengthening the hypothesis that the molecular nature of catalytic activation in KDR is similar to that for other receptors.
We conclude from our studies that binding of VEGF to KDR results in rapid internalization of the growth factor plus receptor complex. While the cellular advantage of KDR internalization is not clear, studies done on other receptor kinases may provide clues. Receptor internalization is one mechanism by which cells become desensitized to further growth factor activation. It can be speculated that KDR internalization may prove important for desensitizing endothelial cells to VEGF activation and thus regulating the rate and degree of neovascularization. A second potential role for receptor internalization is to trac growth factor to the nucleus; this is the case for the bFGFR (Prudovsky et al., 1994) and there is evidence that bFGF internalization leads to modi®cations in gene expression. To date the issue of VEGF tracking to the nucleus has not been investigated.
Our ®nding that the rate of internalization is delayed in KDR(Y1054,1059F) expressing cells indicates that receptor catalytic activity is required for the internalization mechanism. VEGF was internalized in the KDR(Y1054,1059F), this most likely represents the basal rate of receptor turnover and not a cellular process that is dependent upon growth factor. It remains to be determined whether autophosphorylation of KDR tyrosines 1054 and 1059 (and thus maximal receptor catalytic activity) is required for internalization because this leads to an increased rate of receptor autophosphorylation (which occurs for the FGFR (Mohammadi et al., 1996) ) or alternatively to phosphorylation of a cellular substrate (as would appear to be the case for the EGFR (Wiley et al., 1991) and FGFR (Mohammadi et al., 1996) ).
Materials and methods

Cell lines
Human embryonic kidney epithelial (293) cells were grown in Delbecco's modi®ed Eagle's medium (DMEM) (Gibco BRL; Gaithersburg, MD, USA) containing 10% fetal calf serum plus penicillin G (100 U/ml) and streptomycin sulfate (1 mg/ml). Transfected 293 cells were maintained in this media plus 0.4 mg/ml puromycin (Sigma Chemicals; St. Louis, MO, USA). Bovine aortic endothelial (BAE) cells were grown in DMEM plus 10% calf serum, 1 ng/ml bFGF (R&D Systems; Minneapolis, MN, USA) and antibiotics. For radioligand binding assays, the BAE cells were plated in this media minus bFGF.
Site-directed mutagenesis of the KDR cDNA Synthetic oligonucleotides were chemically synthesized and employed as mismatched primers to introduce either a single (at tyrosines 951 or 996) or a double mutation (at tyrosines 1054 and 1059). A two step polymerase chain reaction strategy was used. In the ®rst step two separate PCR reactions were carried out using the full length KDR cDNA as a template. For constructing the KDR(Y951) mutant, reaction 1 included the oligonucleotide primers 5'-GGGAAAGACTTCGTTGGAGC-3' (encompasses site of mutation which is underlined) and 5'-CCCACAGCAAAA-CACCAAAAGACC-3' (3' to a unique AatII site in the KDR cDNA). Reaction 2 used the oligonucleotide primers 5'-GCTCCAACGAAGTCTTTCCC-3' (encompasses site of mutation in the reverse orientation) and 5'-GGCCTCTA-CACCTGCCAGGCATGC-3' (5' to a unique SphI site in the KDR cDNA). The PCR products were gel puri®ed and suspended in 50 ml of TE. The second step of the cloning strategy involved a PCR reaction using 1 ml of each product from the ®rst step and the oligonucleotide primers 3' to the unique AatII site and 5' to the unique SphI site. The PCR product was gel puri®ed, digested with AatII plus SphI, and used to replace the SphI/AatII fragment of the KDR cDNA in a eukaryotic expression vector (Dougher et al., 1997) . Identical strategies were used to make the KDR(Y996F) and KDR(Y1054,1059F) cDNA constructs. DNA sequencing was used to verify that no other mutations were introduced during these procedures. The expression vectors were transfected into 293 cells using a SuperFect transfection kit (Qiagen Inc., Santa Clara, CA, USA). Selection of transfected cells was done using puromycin, and expression of receptor in clonally selected cells was done using Western blot analysis with an anti-KDR antibody.
Immunoprecipitation of tyrosine phosphorylated proteins
Transfected 293 cells were grown to con¯uence on 6 cm dishes. The cells were washed once with phosphate buered saline (PBS) and then serum free DMEM was added overnight. The media was replaced with 1.0 ml of serum free DMEM containing 10 mM HEPES, pH 7.4 plus 1 mM Na 3 VO 4 . Thirty minutes later 50 ng/ml VEGF 165 (R&D Systems; Minneapolis, MN, USA) was added. Incubation of cells with VEGF was done at either 48C for 1 h (Figure 3) or at 378C for times ranging from 1 ± 20 min ( Figures 1, 4 and 5). All subsequent steps were done at 48C. The cells were washed once with PBS and then scraped from the dishes and pelleted. The cells were suspended in 0.5 ml of solubilization buer (20 mM Tris, pH 8.0, 0.5 mM Na 3 VO 4 , 30 mM sodium¯uoride, 30 mM sodium pyrophosphate, 50 mM NaCl, 5 mM EDTA, 0.5% Triton X-100, 0.5% NP40, 1 mM PMSF) and incubated for 45 min. The samples were then microfuged for 15 min and the supernatants saved. Agarose conjugated antiphosphotyrosine (Upstate Biotechnology; Lake Placid, NY, USA), 10 ml, was then added for 90 min. The samples were pelleted and the anity matrix washed ®ve times with 1 ml of solubilization buer. Gel sample buer (100 mM Tris, pH 6.8, 10% glycerol, 4% SDS, 10% 2-mercaptoethanol, 0.02% bromophenol blue), 100 ml, was added and the samples were boiled for 5 min. Twenty ml was loaded onto a 8% SDS ± PAGE gel, and electrophoresed to the bottom of the gel. The gels were transferred to nitrocellulose which were then placed in blocking solution (Tris-buered saline plus 1% TWEEN (TBS-T) containing 1% gelatin) for 2 h. The appropriate cell signaling antibody, 1 mg in 10 ml of TBS-T, was added and the blots were incubated overnight at 48C. The blots were washed twice for 20 min using TBS-T and then incubated for 2 h at room temperature with horse radish peroxidase conjugated goat anti-mouse antibody (Amersham, Chicago, IL, USA). Visualization of tyrosine phosphorylated proteins was done using an ECL kit (Amersham, Chicago, IL, USA). Antibodies against PLCg, p 125 FAK and paxillin were purchased from Transduction Laboratories (Lexington, KY, USA). The anti-KDR antibody was generated in rabbits against a bacterially expressed cytosolic domain of the receptor.
Expression of the PLCg-derived SH2 domains and its interaction with KDR-derived peptides PCR was used to amplify cDNA encoding both SH2 domains of PLCg from a human brain cDNA library (Clonetech, San Diego, CA, USA). The oligonucleotide primers 5'-AAGGATCCAATGAGAAGTGGTTCCAT-GGG-3' and 5'-AAGGATCCTGACAGCTTCATCTT-GCGGTATAG-3' were utilized. The PCR product was gel puri®ed, digested with BamHI and cloned into the pGEX4T1 (Pharmacia; Piscataway, NJ, USA) bacterial expression vector and transfected into BL21 LysS E.Coli. Isopropyl b-D-thiogalactoside (IPTG) induction was done at room temperature for 4 h, and recombinant protein was puri®ed using a glutathione sepharose 4B resin. Biotinylated peptides (GKDYVAGAIPV, EDLYKDFLATL, DNDYIIPLP) were synthesized using phosphotyrosine. The peptides, 5 mg, were incubated with 25 ml of streptavidin-coupled agarose (Sigma, St. Louis, MO, USA) in 1 ml of TBS-T containing 1% BSA for 2 h at 48C. Then resin was washed ®ve times with this buer and suspended in 1 ml. The recombinant PLCg-derived SH2 domain protein, 10 mg, was added and the resin was rocked for 1 h at 48C. The resin was washed ®ve times with TBS-T and suspended in 200 ml of gel sample buer. Samples, 40 ml, were run on 14% polyacrylamide gels. Western analysis was done using an antibody to glutathione Stransferase (GST).
Kinases activity in receptor immunoprecipitates
KDR, KDR(Y1054,1059F) and KDR(Y996F) expressing cells were grown to con¯uence on 10 cm dishes, and then incubated overnight in serum free DMEM. The media was replaced with serum free DMEM containing 20 mM HEPES, pH 7.4 plus 1 mM Na 3 VO 4 , and the cells were incubated for 1 h at 48C. All subsequent steps were done at 48C. Fifty ng/ml VEGF was added and the cells were incubated for 1 h. The media was aspirated, the cells were washed with ice cold PBS, scraped from the dishes in PBS, and pelleted. The cells were suspended in 1 ml of solubilization buer, incubated for 1 h and pelleted. Anti-KDR antibody, 1 mg, was added to the soluble samples for 30 min, and then 15 ml of protein-A agarose was added. After 2 h, the resins were pelleted and washed ®ve times with solubilization buer.
Kinase activity was measured in the immunoprecipitates as follows. The ®nal concentration of reagents were: 50 mM HEPES, pH 8.0, 0.1 mM Na 3 VO 4 , 10 mM MnCl 2 , 25 mM ATP, 50 mCi [ 33 P]ATP (Amersham, Chicago, IL, USA), 50 mg/ml poly(Glu:Tyr 4 : 1) (Sigma, St. Louis, MO, USA). The reactions were carried out at 48C in a total volume of 200 ml. At various times, the samples were microfuged for 10 s to pellet the resin, and 25 ml samples of the media were spotted onto phosphocellulose disk ®lters (GibcoBRL, Gaithersberg, MD, USA). The ®lters were washed three times for 15 min with 0.5% phosphoric acid, and then counted by liquid scintillation counting.
Radioligand Binding
Transfected 293 cells were grown to con¯uency on 24-well (4 610 5 cells/well) cell culture plates. The cells were washed twice with PBS, and 0.2 ml of DMEM containing 0.15% gelatin and 25 mM HEPES, pH 7.4 was added. [ 125 I]VEGF (Amersham, Chicago, IL, USA) at concentrations ranging from 1-300 pM, 5 mM VEGF and other additions were added to appropriate dishes adjusting the ®nal volume to 0.25 ml. Cells were incubated for 4 h at 48C. A 50 ml sample of the media for each dish was taken to determine the concentration of free radioligand, and the cells were washed three times with ice cold PBS containing 0.1% BSA. The cells were extracted from the dishes by incubating them for 30 min with 1% Triton X-100 in 100 mM sodium phosphate, pH 8.0, and radioactivity of the extracts was determined in a gamma counter. Speci®c [ 125 I]VEGF binding is de®ned as the dierence seen in the presence and absence of 5 nM nonradioactive VEGF. Duplicate samples were analysed.
